2021³â Á¦72Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ : 2021-04-29±³À°ÀÏÀÚ : 2021-04-29
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (¿ÀÇÁ¶óÀÎ: ¼¿ï µå·¡°ï½ÃƼ È£ÅÚ 2Ãþ ÇѶóȦ ¿Ü)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ) 2021³â Á¦72Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-3473-0284
À̸ÞÀÏ :
kda@derma.or.kr ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ 23 ½Ã°£ 4ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í ¿ÀÇÁ¶óÀÎ Á¤È¸¿ø 70,000 ÁØȸ¿ø 30,000 / ¿Â¶óÀÎ Á¤È¸¿ø 50,000 ÁØȸ¿ø20,000 ¸¸65¼¼ ÀÌ»ó ¸éÁ¦ / ºñȸ¿ø 500,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-29 11:00~11:05 »çÁøÃÔ¿µ ()
ÈÞ½Ä 04-29 12:10~12:30 Coffee Break ()
ÈÞ½Ä 04-29 14:30~15:00 Coffee Break ()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 12:30~12:55 1. Laser ÀÌÁ¾Èñ(¼º±Õ°üÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 12:55~13:00 2. Q&A ()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 13:00~13:25 3. Scalpel surgery and other procedures ±èÈƼö(ºÎ»êÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 13:25~13:30 4. Q&A ()
±âŸ 04-29 ¹éµÎȦ 1 12:30~12:33 1. Introduction Chair()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 12:33~12:48 2. Alopecia areata in childhood: Diagnosis & treatment ÀÌ¿µ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 12:48~13:03 3. Genetic hair diseases in children ½ÅÇöÅÂ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 13:03~13:18 4. Trichotillomania and miscellaneous hair loss Àå¿ëÇö(°æºÏÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 1 13:18~13:30 5. Q&A ()
±âŸ 04-29 ¹éµÎȦ 1 13:30~13:33 1. Introduction Chair()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 13:33~13:53 2. How to classify pseudolymphoma ¹ÚÁöÇý(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 13:53~14:08 3. Histologic simulators of mycosis fungoides ¹ÚÁ¾ºó(°í½ÅÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 14:08~14:23 4. Rare mimicker: cutaneous IgG4-related disease ±èµ¿Çö(Â÷ÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 1 14:23~14:30 5. Q&A ()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 15:00~15:02 1. Overview: ´ë»çÁõÈıº°ú ÇǺΰú Áø·á À强Àº(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 15:02~15:22 2. ´ë»çÁõÈıºÀÇ ÇöÀç¿Í ¹Ì·¡ ±èÀ±Á¤(ÇѸ²ÀÇ´ë °³²¼º½Éº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 15:22~15:40 3. ´ë»çÁõÈıº ¾à¸®ÇÐÀÇ ±âÃÊ ±è¼Ò¿ø(¿ï»êÀÇ´ë ¾à¸®Çб³½Ç)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 15:40~15:53 4. ´ë»çÁõÈıº °ü·Ã ¿°Áõ¼º ÇǺÎÁúȯ À强Àº(¿ï»êÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 1 15:53~16:00 5. Q&A ()
±âŸ 04-29 ¹éµÎȦ 1 16:00~16:02 1. Introduction Chair()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 16:02~16:17 2. ÇǺοܰú ¿µ¿ª¿¡¼ ÃÊÀ½ÆÄ °Ë»çÀÇ È°¿ë ¿Àº´È£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 16:17~16:32 3. ÇǺΰúÀÇ ºí·ç¿À¼Ç Áø´ÜÃÊÀ½ÆÄÀÇ ½ÇÀü ±èÇö¿õ(ûÁÖ¿À¶óŬÇǺΰú)
Åä·Ð 04-29 ¹éµÎȦ 1 16:32~16:40 4. Q&A ()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 16:40~16:55 5. No more stitches: Introduction to reflectance confocal microscopy ÀÌ¿µ(Ãæ³²ÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 1 16:55~17:00 6. Q&A ()
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 09:00~09:10 1. ½ÅÀÇ·á±â¼ú Æò°¡ °³¿ä ÃÖÀ¯¼º(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 09:10~09:35 2. ½ÅÀÇ·á±â¼ú µî·ÏÀ» À§ÇÑ È¿°úÀûÀÌ°í Àü·«ÀûÀÎ Áغñ - practical and critical points À̹«¿(Áß¾ÓÀÇ´ë »ý¸®Çб³½Ç/Àü ½ÅÀÇ·á±â¼úÆò°¡»ç¾÷º»ºÎ º»ºÎÀå)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 09:35~10:00 3. Panel discussion : »ç·Ê¸¦ ÅëÇÑ ÇâÈÄ ¼º°øÀûÀÎ ½ÅÀÇ·á±â¼ú µî·Ï ¹æ¾È ¸ð»ö ÀÓ»óÀÇ, ¿¬±¸ÀÚ, ÇÐȸ »óÈ£ °øÁ¶ Çʿ伺 ÁÂÀå ÇãâÈÆ (¼¿ïÀÇ´ë) ¿øÁ¾Çö (¿ï»êÀÇ´ë) À̹«¿ ÃÖÀ¯¼º()
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 16:00~16:20 1. â¾÷À» »ý°¢ÇÏ´Â ÇǺΰú Àǻ翡°Ô ¾È°Ç¿µ((ÁÖ)°í¿î¼¼»óÄÚ½º¸Þƽ ´ëÇ¥)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 16:20~16:35 2. ÇǺΰú ÀÇ»ç¶ó¼ ´õ À¯¸®ÇÑ ¡®ºÎ¾÷¡¯ÀÇ Á¾·ù¿Í Àü¸Á ±¸º»Ã¶(³ªÀ½ÇǺΰú)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 16:35~17:00 3. Panel discussion ÁÂÀå ¾È°Ç¿µ ±¸º»Ã¶()
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 09:00~09:15 1. Surgical anatomy of head and neck ±èÈƼö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 09:15~09:30 2. Surgical instrument, suture and dressing materials ±è¹Î¼º(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 09:30~09:40 3. Local and regional anesthesia ±èÁØ¿µ(°æºÏÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 09:40~10:00 4. Various biopsy methods and suture technique ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 1 10:00~11:00 5. Practice session (60min) ½Ç½À¸àÅä: ´ëÇѹ̿ëÇǺοܰúÇÐȸ ÀÓ¿øÁø()
±âŸ 04-29 ÇѶóȦ 1~3 10:00~10:05 1. Introduction Chair()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 10:05~10:50 2. ÇѼ¾º´ÀÇ ¿Ü°úÀû Ä¡·á ¹ÚÇâÁØ(°¡ÃµÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 10:50~11:00 3. Q&A ()
±âŸ 04-29 ÇѶóȦ 1~3 13:30~13:35 1. Introduction Chair()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 13:35~14:20 2. Æ÷½ºÆ® Äڷγª ½Ã´ëÀÇ ¼ÒÅë, Àü¹®°¡ À¯Æ©ºê ä³ÎÀÇ ABC ¿ìâÀ±(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 04-29 ÇѶóȦ 1~3 14:20~14:30 3. Q&A ()
±âŸ 04-29 ÇѶóȦ 1~3 15:00~15:05 1. Introduction Chair()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 15:05~15:50 2. Effect of dermatologic drugs in my experience ³ë¿µ¼®(ÇѾçÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 15:50~16:00 3. Q&A ()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 09:00~09:48 2. ±¹³» ÁßÁõÇǺÎÀ¯ÇعÝÀÀ ÇöȲ°ú ÇÇÇر¸Á¦Á¦µµ (Severe cutaneous adverse reaction: current status and adverse drug reaction relief system in Korea) °Çý·Ã(¼¿ïÀÇ´ë ¾Ë·¹¸£±â³»°ú)
Åä·Ð 04-29 ÇѶóȦ 1~3 09:48~10:00 3. Q&A ()
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 16:00~16:48 2. Äڷγª-19 °¨¿°°ú ÃֽŠ¹é½Å ¾÷µ¥ÀÌÆ® ±è¿ìÁÖ(°í·ÁÀÇ´ë °¨¿°³»°ú)
Åä·Ð 04-29 ÇѶóȦ 1~3 16:48~17:00 3. Q&A ()
±âŸ 04-29 ÇѶóȦ 1~3 11:10~11:13 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 11:13~11:58 2. Long-term efficacy and safety of dutasteride in AGA ÇãâÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 11:58~12:10 3. Q&A ()
±âŸ 04-29 ÇѶóȦ 1~3 08:00~08:03 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 08:03~08:28 2. Fast and long lasting response with secukinumab: RCTs to RWEs Á¤±âÇå(°æÈñÀÇ´ë)
±³À°½Ã°£ 04-29 ÇѶóȦ 1~3 08:28~08:53 3. Protecting patients progressing to PsA: Disease interception in psoriasis ¹æöȯ(°¡Å縯ÀÇ´ë)
Åä·Ð 04-29 ÇѶóȦ 1~3 08:53~09:00 4. Q&A ()
±âŸ 04-29 ¹éµÎȦ 2 12:30~12:33 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ¹éµÎȦ 2 12:33~12:58 2. The evolving evidences of type 2 inflammation À̵¿ÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éµÎȦ 2 12:58~13:23 3. Real world considerations for dupilumab treatment ±èÇý¿ø(ÇѸ²ÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 2 13:23~13:30 4. Q&A ()
±âŸ 04-29 ¹éµÎȦ 2 13:30~13:33 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ¹éµÎȦ 2 13:33~14:18 2. What¡¯s advanced? Long-term & more patient-tailored updates of risankizumab Á¶¼ºÁø(¼¿ïÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 2 14:18~14:30 3. Q&A ()
±âŸ 04-29 ¹éµÎȦ 2 15:00~15:03 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ¹éµÎȦ 2 15:03~15:48 2. Myth vs fact in ixekizumab ±èµ¿Çö(Â÷ÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 2 15:48~16:00 3. Q&A ()
±âŸ 04-29 ¹éµÎȦ 2 16:00~16:03 1. Introduction Chair(Chair)
±³À°½Ã°£ 04-29 ¹éµÎȦ 2 16:03~16:48 2. ³Ä¡¼º ¼Õ¹ßÅéÁø±ÕÁõÀÇ ¿øÀΰú Ä¡·áÀü·« ½Å¹Î°æ(°æÈñÀÇ´ë)
Åä·Ð 04-29 ¹éµÎȦ 2 16:48~17:00 3. Q&A ()
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 10:00~10:05 1. Current status of photodermatoses in Korea ¼´ëÇå(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 10:05~10:20 2. Immunologically mediated photodermatoses Àå¹Î¼ö(°í½ÅÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 10:20~10:35 3. Photosensitivity induced by exogenous agents ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 10:35~10:50 4. Photoaggravated dermatoses À̽ÃÇü(¼¿ïÀÇ´ë)
Åä·Ð 04-29 ¹éÁ¦È¦ 1~5 10:50~11:00 5. Q&A ()
±âŸ 04-29 ¹éÁ¦È¦ 1~5 12:30~12:35 1. Overview Chair(Chair)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 12:35~12:50 2. New insights into keratinocytes in atopic dermatitis Àå¿ëÇö(°æºÏÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 12:50~13:05 3. Recent advances on outermost skin layers of atopic dermatitis ÃÖÀÀÈ£(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 13:05~13:20 4. Recent advances on skin inflammation in atopic dermatitis ¹Úâ¿í(¿¬¼¼ÀÇ´ë)
Åä·Ð 04-29 ¹éÁ¦È¦ 1~5 13:20~13:30 5. Q&A ()
±âŸ 04-29 ¹éÁ¦È¦ 1~5 13:30~13:35 1. Overview Chair(Chair)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 13:35~13:50 2. Immunopathophysiology of HSV infection in skin ±èµµ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 13:50~14:05 3. Immunopathophysiology of VZV infection in skin ¹Ú¿µ¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 14:05~14:20 4. Immunopathophysiology of HPV infection in skin ±èÁ¤¼ö(ÇѾçÀÇ´ë)
Åä·Ð 04-29 ¹éÁ¦È¦ 1~5 14:20~14:30 5. Q&A ()
±âŸ 04-29 ¹éÁ¦È¦ 1~5 15:00~15:05 1. Overview Chair(Chair)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 15:05~15:20 2. Diagnosis and treatment of candidiasis ¹Úâ¿í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 15:20~15:35 3. Diagnosis and treatment of cryptococcosis ³ªÂùÈ£(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 04-29 ¹éÁ¦È¦ 1~5 15:35~15:50 4. Diagnosis and treatment of aspergillosis ¹Ú°æ´ö(°æºÏÀÇ´ë)
Åä·Ð 04-29 ¹éÁ¦È¦ 1~5 15:50~16:00 5. Q&A ()